Boehringer Ingelheim Press Releases

Press Release Subscription: Signup here to the Boehringer Ingelheim Newsletter to receive press-releases via email.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

Boehringer Ingelheim and the Muskan Foundation inaugurate facility for children with multiple disabilities

PRESS RELEASE 18 Dec 2018 at 09:30

Boehringer Ingelheim and the Muskan Foundation inaugurate facility for children with multiple disabilities

Read more on Boehringer Ingelheim and the Muskan Foundation inaugurate facility for children with multiple disabilities
PRESS RELEASE 17 Dec 2018 at 10:00

Boehringer Ingelheim launches a tool to aid in the prevention of African swine fever

Read more on Boehringer Ingelheim launches a tool to aid in the prevention of African swine fever
PRESS RELEASE 13 Dec 2018 at 08:00

Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK® HVT + IBD since 2006

Read more on Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK® HVT + IBD since 2006
PRESS RELEASE 11 Dec 2018 at 09:00

Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market

Read more on Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market
PRESS RELEASE 04 Dec 2018 at 13:00

Boehringer Ingelheim launches "LastMile" initiative in Sub-Saharan Africa

Read more on Boehringer Ingelheim launches "LastMile" initiative in Sub-Saharan Africa
PRESS RELEASE 28 Nov 2018 at 08:00

Boehringer Ingelheim announces two new claims for Nexgard® and Nexgard Spectra® in the EU and Australia

Read more on Boehringer Ingelheim announces two new claims for Nexgard® and Nexgard Spectra® in the EU and Australia
PRESS RELEASE 22 Nov 2018 at 08:00

Boehringer Ingelheim partners with Ipsos to gain insights on human-animal bond in Europe

Read more on Boehringer Ingelheim partners with Ipsos to gain insights on human-animal bond in Europe
PRESS RELEASE 15 Nov 2018 at 12:30

Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies

Read more on Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals

PRESS RELEASE 26 Oct 2018 at 11:00

Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals

Read more on Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals
PRESS RELEASE 19 Oct 2018 at 12:00

Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC

Read more on Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC
PRESS RELEASE 12 Oct 2018 at 13:00

Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in France

Read more on Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in France
New Health Project 'Elephants' in India

PRESS RELEASE 12 Oct 2018 at 10:00

Ingelheim increases awareness of health with the micro enterprise project ‘Elephants’ in South India

Read more on Ingelheim increases awareness of health with the micro enterprise project ‘Elephants’ in South India
PRESS RELEASE 11 Oct 2018 at 07:00

2018 Animal Welfare Medals: Boehringer Ingelheim recognises outstanding research in animal health

Read more on 2018 Animal Welfare Medals: Boehringer Ingelheim recognises outstanding research in animal health
PRESS RELEASE 28 Sep 2018 at 08:00

Boehringer Ingelheim is committed to joining forces in the global fight against rabies

Read more on Boehringer Ingelheim is committed to joining forces in the global fight against rabies
PRESS RELEASE 27 Sep 2018 at 08:00

New vaccine against Bovine Respiratory Disease: Boehringer Ingelheim reaffirms its focus on prevention

Read more on New vaccine against Bovine Respiratory Disease: Boehringer Ingelheim reaffirms its focus on prevention
PRESS RELEASE 13 Sep 2018 at 08:00

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Read more on Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
PRESS RELEASE 04 Sep 2018 at 14:00

Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases

Read more on Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
PRESS RELEASE 04 Sep 2018 at 10:00

Boehringer Ingelheim launches the first liquid solution for hypertension in cats

Read more on Boehringer Ingelheim launches the first liquid solution for hypertension in cats
PRESS RELEASE 06 Aug 2018 at 08:00

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis

Read more on Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
PRESS RELEASE 01 Aug 2018 at 10:00

Boehringer Ingelheim achieves modest growth in the first half of 2018

Read more on Boehringer Ingelheim achieves modest growth in the first half of 2018